Effect of fibrin sealant on blood loss following total knee arthroplasty: A systematic review and meta-analysis

AbstractObjectiveA systematic review of randomized controlled trials was conducted to examine the efficacy of fibrin sealants for the reduction of postoperative blood loss and allogeneic red blood cell transfusion in total knee arthroplasty (TKA).MethodsStudies published through May 2013 were identified from PubMed, Embase, the Cochrane library, ScienceDirect, and other databases. Two independent reviewers assessed the quality of methodology using the Grade of Recommendations Assessment, Development and Evaluation approach and extracted data from literature. The mean difference (MD) of blood loss, hemoglobin loss, and risk ratios (RR) of transfusion rate and adverse events in the fibrin-treated and placebo groups were pooled throughout the study. The relevant data were analyzed using Stata 11.0 software.ResultsEight studies were included in the review, with a total sample size of 558 patients. The drainage blood loss [MD = −354.02 mL, 95% confidence interval (CI) (−500.87 to −207.18); P < 0.05], reduction in calculated total blood loss [MD = −402.12, 95% CI (−599.16 to −205.08); P < 0.05], hemoglobin loss [MD = −0.86 g/dL, 95% CI (−1.10 g/dL to −0.61 g/dL); P < 0.05], and transfusion rate [RR = 0.62, 95% CI (0.45–0.86); P < 0.05] were all significantly reduced following treatment with fibrin sealants. There were no significant differences in the incidence of adverse events [RR = 0.69, 95% CI (0.32–1.59); P > 0.05] among the study groups.ConclusionsThe results of the present meta-analysis suggest that fibrin sealants for patients undergoing TKA may reduce blood loss and maintain higher hemoglobin levels, particularly when fibrin sealants are used at higher dosage. Furthermore, fibrin sealants do not increase the risk of postoperative deep vein thrombosis, superficial infection, pulmonary embolism, and hematoma. Further evaluation is required to confirm our findings before fibrin sealants can be used in patients undergoing TKA.Level of evidenceII